FogPharma
1 follower
FogPharma is dedicated to the creation of a new class of medicines that target human disease drivers currently considered “undruggable.” The company’s cell-penetrating miniproteins (CPMPs) combine the targeting power of protein therapeutics with the cell-penetrating ability of small molecules. This... Read more
Org chart
Mathai Mammen
Advisor & CEO Designate
Keith Orford
CMO & EVP, Clinical & Translational Sciences
Sandra Smith
VP, Head of People
John Mcgee
VP, De Novo Discovery
Thomas Kotarako
SVP, Finance
Kristen Stants
Chief People Officer
Dave Varon
Principal Data Engineer
Amanda Garofalo
Senior Director Clinical Operations
John Doherty
Head Of Facility
Ashley Kancler
Senior Administrative Business Partner
